Novartis Venture Fund — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

Nabriva Therapeuticsnabriva.comSeries B · Apr 2015 · $120M

BiotechDublin 1

Jennifer Schranz(Executive Officer)Axel Bolte(Director)Gary Sender(Executive Officer)Theodore Schroeder(Executive Officer, Director)Robert Crotty(Executive Officer)Colin Broom(Director)

Co-investorsAisling Capital EcoR1 Capital Frazier Life Sciences Longitude Capital MESA VERDE VENTURE PARTNERS

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.